alphaveCONCORDBIO₹1,445.20

Concord Biotech Ltd.

₹ CrorePeersBIOCON DIVISLAB CAPLIPOINT EMCURE BLUEJET ERIS GRANULES ACUTAASMcap ₹15,119 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	571.7	791.8	785.7	785.7
+ Capital Work-in-Progress	211.5	50.1	78.2	78.2
+ Investment Property	0.0	0.6	—	—
+ Goodwill	0.0	0.0	0.4	0.4
+ Other Intangibles	3.6	2.3	2.4	2.4
+ Intangibles under Development	0.0	0.5	1.2	1.2
+ Investments (Equity Method)	2.1	0.7	3.6	3.6
+ Non-current Investments	0.0	18.0	84.9	84.9
+ Other Non-current Financial Assets	5.0	12.6	6.5	6.5
Non-current Financial Assets	5.0	30.6	91.4	91.4
+ Deferred Tax Assets	2.7	1.8	5.8	5.8
+ Other Non-current Assets	8.0	20.6	15.9	15.9
Total Non-current Assets	804.5	899.0	984.6	984.6
Current Assets
+ Inventories	208.0	239.7	326.4	326.4
+ Current Investments	243.7	316.5	402.1	402.1
+ Trade Receivables	349.6	521.7	460.2	460.2
+ Cash & Cash Equivalents	15.1	0.9	12.2	12.2
+ Other Bank Balances	31.9	0.3	1.4	1.4
+ Short-term Loans	0.0	40.8	0.0	0.0
+ Other Current Financial Assets	19.4	15.4	25.2	25.2
Current Financial Assets	659.8	895.6	901.1	901.1
+ Other Current Assets	28.5	15.4	22.7	22.7
Total Current Assets	896.2	1,135.2	1,250.1	1,250.1
Total Assets	1,700.7	2,034.3	2,234.7	2,234.7
Equity
+ Equity Share Capital	10.5	10.5	10.5	10.5
+ Other Equity / Reserves	1,516.2	1,802.3	2,006.6	2,006.6
Equity — Owners of Parent	1,526.6	1,812.7	2,017.1	2,017.1
+ Minority Interest	—	0.0	-1.9	-1.9
Total Equity	1,526.6	1,812.7	2,015.1	2,015.1
Liabilities
+ Other Non-current Financial Liab	1.9	0.6	1.4	1.4
Non-current Financial Liabilities	1.9	0.6	1.4	1.4
+ Provisions — Non-current	2.0	2.8	3.7	3.7
+ Deferred Tax Liabilities	28.1	34.0	45.4	45.4
Non-current Liabilities	31.9	37.5	50.5	50.5
+ Borrowings — Current	6.2	0.4	0.0	0.0
+ Trade Payables	94.4	113.0	101.9	101.9
+ Other Current Financial Liab	25.8	43.7	43.6	43.6
Current Financial Liabilities	126.5	157.1	145.5	145.5
+ Provisions — Current	3.9	5.5	11.2	11.2
+ Current Tax Liabilities	5.5	10.1	0.0	0.0
+ Other Current Liabilities	6.3	11.3	12.3	12.3
Current Liabilities	142.2	184.1	169.1	169.1
Total Liabilities	174.1	221.5	219.6	219.6
Total Equity & Liabilities	1,700.7	2,034.3	2,234.7	2,234.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	6.0	14.7	14.7
+ Dues to Other Creditors — Current	—	107.1	87.2	87.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.